JP Morgan maintains a neutral stance on Bajaj Finance, citing strategic growth plans and market share ambitions. Goldman Sachs also holds a neutral rating for Biocon, following its planned integration with Biocon Biologics. Kotak Institutional Equities initiates coverage on Tata Capital with an ‘add’ rating, anticipating strong loan growth.